*Disclaimer: As of September 29, 2023, NeuroMend no longer offers Spravato treatments. We apologize for any inconvenience and encourage you to consult with our team or your healthcare provider for alternative options.
The FDA approved form of Ketamine (Spravato or Esketamine) hitting the market has sparked many consumers' curiosity. What is it? Is it covered by my insurance? Keep reading for answers to a few questions you may have about Spravato™.
Insurance providers are now offering coverage for SPRAVATO™!
People who are currently struggling with major depressive disorder (MDD) may have treatment resistant depression (TRD) if they have not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode. Spravato™ is a great treatment option for these people.
What is SPRAVATO™(esketamine) CIII nasal spray?
Spravato™ is a prescription medicine (nasal spray), used along with an antidepressant taken by mouth to treat:
- Adults with treatment-resistant depression (TRD)
- Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions
The following insurance companies have provided coverage for SPRAVATO™:
- Blue Cross Blue Shield
- Humana Military/ Triwest
- Multiplan/ PHCS
- Zelis/ PPO Plus
- United Healthcare
- United Behavioral Health
- Cigna Behavioral Health
- Peoples Health
We are an Evidence-Based Center of Excellence and the leading provider of Ketamine Infusions, IV Infusions and Ketamine Consulting Services for Ketamine Clinics and IV Therapy Clinics.
We Provide Effective Treatment For The Following Conditions: Major Depressive Disorders, Post-traumatic Stress Disorder (PTSD), Bipolar Depression, Obsessive Compulsive Disorder (OCD), Chronic Migraines, Severe Anxiety, Fibromyalgia and Chronic Pain Syndromes